Position in MYGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$299,118
+$12,319 QoQ
Shares Held
52,385
+489.8% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 196 holders
Holding Since
Jun 2021
3 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $58,986,014 across 22 Diagnostics & Research names. MYGN ranks #16 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
54,764 | $10,431,446 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
19,936 | $9,995,112 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
14,787 | $7,784,468 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
35,788 | $6,914,957 | |
| 5 | NTRA |
Natera, Inc.
|
23,730 | $6,441,508 | |
| 6 | A |
Agilent Technologies, Inc.
|
28,456 | $3,779,810 | |
| 7 | LH |
Labcorp Holdings Inc.
|
11,004 | $3,081,120 | |
| 8 | DGX |
Quest Diagnostics Inc
|
12,508 | $2,651,070 |
All Filings in MYGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $299,118 | 52,385 | Shares | Sole | 2026-08-12 | |
| 2021-09-30 | $286,799 | 8,882 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $261,397 | 8,548 | Shares | Sole | 2021-07-22 | |
| No filing history on record for this holder in this stock. | ||||||